Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Marton

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Biomed Research International|November 16, 2013
Practical guidance for implementing predictive biomarkers into early phase clinical studiesMatthew J Marton, Russell Weiner
Personalized Medicine|May 17, 2018
Past, current and future approaches to querying MAPK pathway activation: status and clinical implicationsKen Cn Chang, Matthew J Marton
Frontiers in Oncology|May 27, 2014
Navigating the rapids: the development of regulated next-generation sequencing-based clinical trial assays and companion diagnosticsSaumya Pant, Russell Weiner, Matthew J Marton
Plos One|August 31, 2013
Development and validation of a clinical trial patient stratification assay that interrogates 27 mutation sites in MAPK pathway genesKen C N Chang, Stefan Galuska, Russell Weiner, et al.
Plos One|July 1, 2015
Analytical Validation of AmpliChip p53 Research Test for Archival Human Ovarian FFPE SectionsMatthew J Marton, Andrew R McNamara, D Michele Nikoloff, et al.
The Journal of Biological Chemistry|December 21, 2002
Functional interactions between yeast translation eukaryotic elongation factor (eEF) 1A and eEF3Monika Anand, Kalpana Chakraburtty, Matthew J Marton, et al.
Scientific Reports|January 16, 2019
Measuring Tumor Mutational Burden (TMB) in Plasma from mCRPC Patients Using Two Commercial NGS AssaysPing Qiu, Christian H Poehlein, Matthew J Marton, et al.
Oncogene|May 29, 2002
Identification of genes over-expressed in small cell lung carcinoma using suppression subtractive hybridization and cDNA microarray expression analysisChaitanya S Bangur, Ann Switzer, Liqun Fan, et al.
BMC Cancer|December 14, 2022
Concordance between single-nucleotide polymorphism-based genomic instability assays and a next-generation sequencing-based homologous recombination deficiency testRazvan Cristescu, Xiao Qiao Liu, Gladys Arreaza, et al.
International Journal of Molecular Sciences|September 23, 2016
Pre-Analytical Considerations for Successful Next-Generation Sequencing (NGS): Challenges and Opportunities for Formalin-Fixed and Paraffin-Embedded Tumor Tissue (FFPE) SamplesGladys Arreaza, Ping Qiu, Ling Pang, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Biomed Research International|November 16, 2013
Practical guidance for implementing predictive biomarkers into early phase clinical studiesMatthew J Marton, Russell Weiner
Personalized Medicine|May 17, 2018
Past, current and future approaches to querying MAPK pathway activation: status and clinical implicationsKen Cn Chang, Matthew J Marton
Frontiers in Oncology|May 27, 2014
Navigating the rapids: the development of regulated next-generation sequencing-based clinical trial assays and companion diagnosticsSaumya Pant, Russell Weiner, Matthew J Marton
Plos One|August 31, 2013
Development and validation of a clinical trial patient stratification assay that interrogates 27 mutation sites in MAPK pathway genesKen C N Chang, Stefan Galuska, Russell Weiner, et al.
Plos One|July 1, 2015
Analytical Validation of AmpliChip p53 Research Test for Archival Human Ovarian FFPE SectionsMatthew J Marton, Andrew R McNamara, D Michele Nikoloff, et al.
The Journal of Biological Chemistry|December 21, 2002
Functional interactions between yeast translation eukaryotic elongation factor (eEF) 1A and eEF3Monika Anand, Kalpana Chakraburtty, Matthew J Marton, et al.
Scientific Reports|January 16, 2019
Measuring Tumor Mutational Burden (TMB) in Plasma from mCRPC Patients Using Two Commercial NGS AssaysPing Qiu, Christian H Poehlein, Matthew J Marton, et al.
Oncogene|May 29, 2002
Identification of genes over-expressed in small cell lung carcinoma using suppression subtractive hybridization and cDNA microarray expression analysisChaitanya S Bangur, Ann Switzer, Liqun Fan, et al.
BMC Cancer|December 14, 2022
Concordance between single-nucleotide polymorphism-based genomic instability assays and a next-generation sequencing-based homologous recombination deficiency testRazvan Cristescu, Xiao Qiao Liu, Gladys Arreaza, et al.
International Journal of Molecular Sciences|September 23, 2016
Pre-Analytical Considerations for Successful Next-Generation Sequencing (NGS): Challenges and Opportunities for Formalin-Fixed and Paraffin-Embedded Tumor Tissue (FFPE) SamplesGladys Arreaza, Ping Qiu, Ling Pang, et al.
Pageof 3